美诺华：10月27日召开董事会会议

Group 1 - The core point of the article is that Meinuohua (SH 603538) held its 18th meeting of the fifth board of directors on October 27, 2025, where it reviewed the "2025 Third Quarter Report" and other documents [1] - For the year 2024, Meinuohua's revenue composition is as follows: 96.14% from self-operated pharmaceuticals, 3.52% from trade, and 0.34% from other businesses [1] - As of the time of reporting, Meinuohua has a market capitalization of 5.1 billion yuan [1]